As of Mar 16
| +0.035 / +3.55%|
The 1 analysts offering 12-month price forecasts for Titan Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +96.08% increase from the last price of 1.02.
The current consensus among 1 polled investment analysts is to Hold stock in Titan Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.